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Abstract
This study examined whether the discrepancy between measured and self-identified good weight 
(weight discrepancy) predicts metabolic syndrome (MetSyn). This study included 6,413 
participants enrolled in the Aerobics Center Longitudinal Study (mean follow-up: 4.8 ± 3.8 years). 
Weight discrepancy was defined as measured weight minus self-identified good weight. MetSyn 
was defined using standard definitions. Hazard ratios (HRs) and 95% confidence intervals (95% 
CIs) for incident MetSyn, by weight discrepancy category, were estimated using Cox proportional 
hazards regression. The multivariable-adjusted HR for MetSyn was 3.48 (95% CI = 2.48–4.86) for 
those who maintained higher weight discrepancy over time compared to individuals with lower 
weight discrepancy. Additional adjustment for body mass index did not change this interpretation 
(HR = 3.44; 95% CI = 2.46–4.82). Weight discrepancy may be a useful screening characteristic 
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and target for future interventions to further reduce the risk of chronic weight-related disorders, 
included MetSyn.
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Introduction
Previous cross-sectional research has indicated that larger discrepancies between measured 
and self-identified good weight (i.e., weight discrepancy) have been associated with greater 
dieting frequency, increased snacking, yo-yo dieting, physical inactivity, tobacco use, and 
alcohol consumption (Blake et al., 2013). Individuals with chronically larger weight 
discrepancies had three times greater risk of developing type 2 diabetes compared to 
individuals with smaller weight discrepancies (Wirth, Blake, Hebert, Sui, & Blair, 2014). 
Although this concept of weight discrepancy has not been validated against measures of 
weight dissatisfaction, similarities do exist. For example, weight dissatisfaction also has 
been associated with poor eating habits (e.g., vomiting, binging), increased tobacco and 
alcohol consumption, diagnosed mental illness, poorer self-perceived health, and stress 
(Forrester-Knauss & Zemp Stutz, 2012; Garber, Boyer, Pollack, Chang, & Shafer, 2008; 
Keel, Baxter, Heatherton, & Joiner, 2007; Wade, Zhu, & Martin, 2011).
Although there is little research focusing on weight discrepancy and health outcomes, it is 
possible that the mechanisms of disease progression among those with high weight 
discrepancy may be similar to those proposed for high weight dissatisfaction. Those with 
chronically high weight discrepancies over time may experience excessive stress or negative 
affect, which can potentially induce numerous physiological changes (e.g., immune, 
metabolic, inflammatory, and behavioral changes) potentially increasing the risk of chronic 
disease. A similar mechanism has been proposed for weight dissatisfaction (Cernelic-Bizjak 
& Jenko-Praznikar, 2014; Muennig, 2008; Steptoe & Brydon, 2009) and may be applicable 
for weight discrepancy as well.
Although related to diabetes, metabolic syndrome (MetSyn) includes multiple factors 
associated with poor health characteristics (i.e., abdominal obesity, hypertension, glucose 
intolerance, elevated triglycerides and high-density lipoprotein cholesterol [HDL-C]) 
(Grundy, Brewer, Cleeman, Smith, & Lenfant, 2004). The estimated prevalence of MetSyn 
typically falls between 20%–30% for most countries, with an elevated prevalence mirroring 
a high rate of obesity in the United States, where about 69% of the population is overweight 
(34%) or obese (35%) (Grundy, 2008; Ogden, Carroll, Kit, & Flegal, 2014). Interventions 
targeting poor health behaviors, such as those associated with factors linked to the weight 
discrepancy, have been found to reduce the risk of MetSyn (Yamaoka & Tango, 2012). 
Therefore, we hypothesized that larger weight discrepancies at baseline would be associated 
with increased MetSyn among a population of adults from the Aerobics Center Longitudinal 
Study (ACLS). Additionally, we hypothesized that those with chronically higher weight 
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discrepancies over a period ≥ 2 years will have increased risk of MetSyn compared to those 
who maintained lower weight discrepancies.
Method
Participants
The ACLS enrolled volunteer patients who were referred by doctors or healthcare providers 
for preventive medical examinations from the Cooper Clinic (Dallas, Texas). The Cooper 
Institute Institutional Review Board provided annual protocol review (Blair, Kohl, et al., 
1989). For these analyses, males or females needed to be ≥ 20 years old; have undergone ≥ 2 
clinical examinations between 1986 and 2006; have complete data on all MetSyn 
components; had objectively measured weight; provided self-identified good weight and 
data on selected covariates; and have no baseline MetSyn, diabetes, cardiovascular disease 
(CVD), cancer, ulcers, gallbladder disease, jaundice, hepatitis, cirrhosis, or colon polyps. 
We further excluded those whose body mass index [BMI = weight(kg)/height(m)2] did not 
fall between 18.5 and 50kg/m2, as values outside this range may represent subclinical 
disease.
Procedure
The protocol, including all clinical and physical activity measures, have previously been 
described in detail and followed a standard manual of operations (Blair, Kannel, Kohl, 
Goodyear, & Wilson, 1989).Participants provided informed consent and arrived for the 
clinical examination after ≥ 12-hour fast. Information collected included personal and family 
health histories, fasting blood chemistry analyses, anthropometry, resting blood pressure, 
electrocardiogram, and a maximal graded exercise test. BMI was computed from measured 
weight and height.
Measures
Weight discrepancy—Weight discrepancy was defined as measured weight minus self-
identified good weight, which was obtained by asking participants “What do you consider a 
good weight for yourself?” High weight discrepancy was defined as having a difference in 
measured and self-identified good weight that was above the median (males: 2.72kg; 
females: 3.52kg) and low weight discrepancy was defined as a difference at or below the 
median. Only 5% of the study population had a negative weight discrepancy that was below 
−2.3kg (−5 pounds). Considering that these individuals with a weight discrepancy indicating 
they may want to weigh more (i.e., negative values) were low in frequency and may be 
different than those who want to weigh less, they were removed from the analyses. 
Secondary analyses examined the difference in weight discrepancy using the baseline visit 
and the visit at which ≥ 2 years of follow-up occurred (referred to as time point two) and 
required that participants had at least a third follow-up visit. For secondary analyses, a four-
level weight discrepancy variable was created. A participant having low or high discrepancy 
at both baseline and time point two was classified as ‘stayed low’ or ‘stayed high’, 
respectively. If a participant changed from high to low or low to high, he/she was classified 
as ‘became low’ or ‘became high’, respectively.
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Metabolic syndrome—MetSyn criteria were based on the National Cholesterol 
Education Program Adult Treatment Panel guidelines with modifications from the American 
Heart Association and the National Heart, Lung, and Blood Institute (Grundy et al., 2004). 
MetSyn was defined as exceeding the cut-point values for ≥ 3 of the following components: 
waist circumference (males: ≥ 102cm; females: ≥ 88cm), blood pressure (systolic: ≥ 
130mmHg; diastolic: ≥ 85mmHg), fasting HDL-C (males: < 40mg/dL; females: < 50mg/
dL), fasting triglycerides (≥ 150mg/dL), or fasting glucose intolerance (≥ 100mg/dL).
Covariate data—A standardized medical history questionnaire was used to obtain 
information on smoking habits, alcohol intake, personal history of chronic disease (e.g., 
myocardial infarction, stroke, cancer, hypertension, diabetes, hypercholesterolemia, colon 
polyps) and eating habits. Physical activity was self-assessed by answering questions on 
current moderate and vigorous physical activity and intention regarding future activity 
(Blair, Kohl, et al., 1989; Lee et al., 2012), as well as objectively measured through a 
maximal treadmill test, which provided estimates of cardiorespiratory fitness, using a 
modified Balke protocol (Balke & Ware, 1959; Blair, Kohl, et al., 1989; Lee et al., 2012). 
Resting blood pressure was recorded as the first and fifth Korotkof sounds by ausculatatory 
methods. Serum samples were analyzed for lipids and glucose by a laboratory that 
participates in the CDC Lipid Standardization Program and meets its quality control 
standards.
Statistical Analyses
All analyses were performed using SAS® (version 9.3, Cary, NC). Frequencies or means 
and standard deviations were calculated for demographic and health-related characteristics; 
chi-square or t-tests were used to examine differences between low and high weight 
discrepancy at baseline. Cox proportional hazards regression was used to estimate hazard 
ratios (HRs) and 95% confidence intervals (95%CI) which represent the hazard (i.e., chance) 
of MetSyn incidence among those with high weight discrepancy, compared to those with 
low discrepancy. Follow-up time was the time between the baseline visit and censorship 
(i.e., last examination or first MetSyn ascertainment). The first model was an a prior model 
and adjusted for age, sex, physical inactivity (inactive vs. active as defined by no leisure-
time activity during the three months prior to baseline), smoking status (current vs. non-
smoker), alcohol intake (heavy vs. non-heavy drinker defined as > 14 drinks for men or > 7 
drinks for women per week), and family history of diabetes at baseline (Wirth et al., 2014). 
The variable selection model was based on a backward elimination procedure. Variable 
selections began with a series of bi-variable analyses (i.e., weight discrepancy + covariate). 
If a covariate had a p ≤ .20, it was added to the full model. Backward elimination procedures 
were then used to develop the final models, which included all covariates that when 
removed led to a 10% change in the hazard ratio (HR) of weight discrepancy or were 
statistically significant. The last model was developed by adding BMI to the variable 
selection models. All models were stratified by sex. For secondary analyses, follow-up 
began at time point two until censorship, which had to be at least two years. Cox 
proportional hazards models were applied in the same manner for the secondary analyses as 
described above.
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Average participant (n = 6,168) follow-up time was 4.8 ± 3.8 years with 1,055 (17%) newly 
reported MetSyn cases. At baseline, those with high weight discrepancy compared to low 
were more likely to be smokers (11% vs. 8%, χ2 = 15.5, p < .01), inactive (21% vs. 15%, χ2 
= 41.9, p < .01), younger (mean age: 45.9 vs. 47.0, t = 4.6, p < .01), overweight (mean BMI: 
26.8 vs. 23.5kg/m2, t = −53.2, p < .01), and to have lower treadmill time (mean minutes: 
18.7 vs. 21.1, t = 20.7, p < .01). Weight discrepancy between males and females was 
significantly different (3.9 ± 4.5 vs 5.1 ± 5.4kg, t = −7.1 p < .01, respectively); hence, sex-
specific weight discrepancy medians were created.
The log-log survival curves were parallel, which indicated proportional hazards. The 
primary analyses examined weight discrepancy at baseline only. Among all participants, the 
a priori model (HR = 2.31, 95%CI = 2.03–2.63), variable selection model (HR = 1.96, 
95%CI = 1.70–2.26), and variable selection model plus BMI (HR = 1.22, 95%CI = 1.04–
1.42) indicated greater hazards for MetSyn among those with high weight discrepancy 
compared to those with low weight discrepancy. Statistical significance was similar between 
males and females (Table 1). However, larger magnitudes of effect (i.e., higher HRs) were 
consistently observed among females compared to males.
Secondary analyses examined the change in weight discrepancy over time. These analyses 
included 1,553 participants with an average of 3.4 ± 1.8 years between baseline and time 
point two and an average follow-up time after time point two of 5.7 ± 3.3 years. The number 
of participants who maintained low weight discrepancy, became low, became high, or 
maintained high weight discrepancy was 662 (43%), 218 (14%), 226 (15%), and 447 (29%), 
respectively. Those who maintained high weight discrepancy were consistently more likely 
to develop MetSyn compared with those who maintained low weight discrepancy for the a 
priori (HR = 3.30, 95%CI = 2.37–4.59), variable selection (HR=3.48, 95%CI = 2.49–4.86), 
and variable selection plus BMI models (HR = 3.44; 95%CI = 2.46–4.82). Post hoc 
comparisons indicated that those who changed to low weight discrepancy or those who 
changed to high weight discrepancy had elevated hazard ratios for MetSyn. However, not all 
were statistically significant.
Discussion
Participants who maintained high weight discrepancy over time were more likely to develop 
MetSyn compared with those who maintained low weight discrepancy, even after 
adjustment for BMI. These results are similar to our previous findings showing that those 
who stayed high for weight discrepancy had ≈200% greater diabetes risk compared to those 
who stayed low (Wirth et al., 2014). Literature corroborates our findings that individuals 
who have a low weight discrepancy or are weight satisfied, a potentially similar construct, 
are more likely to engage in healthy behaviors (e.g., physical activity, healthy eating) (Blake 
et al., 2013; Kuk et al., 2009).
It is possible that persistence of high weight discrepancy over time may perpetuate poor 
dietary (e.g., high consumption of fat, protein, sugar) and lifestyle habits (e.g., physical 
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inactivity, tobacco use, alcohol consumption) (Wirth et al., 2014) through mechanisms 
partially driven by the emotional stress and negative affect associated with these constructs 
(Warren, Holland, Billings, & Parker, 2012), a concept adopted from the weight 
dissatisfaction literature (Cernelic-Bizjak & Jenko-Praznikar, 2014). Increased stress and 
negative emotions associated with these constructs may influence metabolic or 
inflammatory processes and lead to adverse behavioral changes, which can influence health 
and potentially lead to MetSyn (Ahluwalia, Andreeva, Kesse-Guyot, & Hercberg, 2013; 
Lavie, Church, Milani, & Earnest, 2011; Pace & Miller, 2009). This hypothesis is partially 
confirmed by baseline findings indicating that those who had a high weight discrepancy 
were more likely to smoke and be inactive. Those who maintained high weight discrepancy 
over time were more likely to stay, or become, inactive (17% vs. 10%, χ2 = 20.1, p < .01) 
and increase their BMI (mean BMI change: +0.28 vs. −0.02 kg/m2, t = −4.7, p < .01) 
compared to those who maintained low weight discrepancy. Additionally, it appears that the 
weight discrepancy can influence disease risk independent of obesity (i.e., adjustment for 
BMI). Similar findings were reported for diabetes (Wirth et al., 2014). These findings are 
similar to those reported for weight dissatisfaction and inflammation. A study by Cernelic-
Bizjak and Jenko-Praznikar found an association between weight dissatisfaction and 
increased c-reactive protein and tumor necrosis factor-α regardless of obesity status 
(Cernelic-Bizjak & Jenko-Praznikar, 2014).
This study benefitted from a large sample size and detailed information on both measured 
and self-identified good weight. This analysis took advantage of a novel measure that 
incorporated both a subjective and objective measure of weight. Simple self-reporting level 
of weight satisfaction/dissatisfaction may capture other aspects of body dissatisfaction that 
are more susceptible to social desirability or are not specific to weight (e.g., muscle 
definition) (Al Sabbah, Vereecken, Abdeen, Coats, & Maes, 2009). The prospective nature 
of this study and exclusion of MetSyn at baseline allowed us to examine the temporality of 
this relationship. Limitations include the primarily European-American, middle-upper 
income population. Without validation analyses, which were not possible in the current 
study, it is difficult to establish whether weight discrepancy is a surrogate for weight 
dissatisfaction. It is unclear why elevated HRs for those who changed to high weight 
discrepancy compared to those who maintained low weight discrepancy did not achieve 
statistical significance. The use of a median split to characterize high versus low weight 
discrepancy is somewhat arbitrary. It is possible that other population groups (e.g., African 
Americans) may have different cultural views on body image and size (Padgett & Biro, 
2003). It is possible that weight discrepancy may lead to different behaviors and outcomes in 
these populations. The fact that the population used in this analysis is at lower risk for 
cardio-metabolic disorders serves to highlight the importance of examining this relationship 
in populations at higher risk of MetSyn. Unfortunately, we could not adjust for social 
desirability, depression, or stress, either because measures for these were not collected or 
data were sparse.
Conclusions
This study demonstrated that greater weight discrepancy was associated with increased 
MetSyn risk. This is disconcerting considering that MetSyn has been associated with life-
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threatening disorders, including CVD (Grundy, 2008; Grundy et al., 2004). Future research 
should continue to elucidate the effect of weight discrepancy on chronic weight-related 
disorders and examine its utility as an indicator for risk in screening for MetSyn. 
Furthermore, weight discrepancy could be used to refine targeting of intervention efforts. 
The emphasis on weight loss in many health promotion programs for chronic disease 
prevention may not include messages that are salient to those with large weight 
discrepancies. These findings suggest that future interventions targeting weight-related 
chronic disorders should incorporate components to address weight discrepancies and focus 
on understanding what factors motivate those who have a large weight discrepancy to 
engage in positive health behaviors which could reduce risk of chronic disorders.
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• Weight discrepancy was defined as measured minus self-reported goal weight.
• Weight discrepancy was associated with smoking and physical inactivity at 
baseline.
• Chronic high weight discrepancy was associated with metabolic syndrome risk.
• Interventions targeting weight discrepancy may help lower metabolic syndrome 
risk.
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Maintained Low 1.00 Referent
Became Low 1.85 1.18–2.90
Became High 1.39 0.86–2.27
Maintained High 3.30 2.37–4.59
a priori modela
Maintained Low 1.00 Referent
Became Low 1.91 1.22–3.00
Became High 1.46 0.89–2.37
Maintained High 3.47 2.48–4.86
Variable selection modelb
Maintained Low 1.00 Referent
Became Low 1.78 1.13–2.82
Became High 1.58 0.96–2.59
Maintained High 3.48 2.49–4.86
Variable selection model + BMIc
Maintained Low 1.00 Referent
Became Low 1.84 1.16–2.92
Became High 1.51 0.91–2.51
Maintained High 3.44 2.46–4.82
Estimates could not be obtained for females due to small sample sizes and therefore, only results for all participants are displayed.
a
Adjusted for baseline age and family history of diabetes and the difference in physical activity, smoking status, and alcohol intake between 
baseline and time point 2.
b
Adjusted for baseline age and the difference in body fat percentage.
c
Same model as model ‘b’ plus adjustment for the difference in BMI.
Abbreviations: HR = hazard ratio; 95% CI = 95% Confidence Interval; BMI = body mass index (kg/m2).
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